logo
GUD logo

Knight Therapeutics Community

TSX:GUD Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

GUD logo
Knight Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

Paladin Acquisition And New Launches Will Expand Market Presence

Key Takeaways Acquisitions and expanded partnerships bolster Knight's Canadian and oncology revenue, enhancing stability and growth prospects. Product launches and strategic contracts in Latin America are anticipated to drive future revenue and improve margins.
View narrative
CA$7.71
FV
21.9% undervalued intrinsic discount
8.41%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
6 days ago author updated this narrative